Legal & Regulatory

Company scaling up manufacturing capacity and anticipates compatibility with its standard distribution channels

Trump administration's plan sounds good but faces severe operational obstacles

One expert's take on the key issues at stake

National Academy of Medicine offers a vaccine allocation ‘framework’; will it be followed?

Generics trade association is confronting a new, post-pandemic era

Little hope for a flurry of executive orders that revive drug importation and rebate transactions in Medicare

Steady progress is occurring in the global effort to track pharmaceutical distribution, even as new technical and business opportunities appear

Robert Wood Johnson Foundation-sponsored study assesses the situation

Position highlights the move toward more at-home services

Industry consortium is poised to manage pharma supply-chain interoperability governance

Quarles & Brady garners an innovative distinction

Strains are showing in drug supplies consumed in treating infected patients

Production quotas for controlled substances are being raised by 15%

Newly initiated trials may prove value—but even then, supplies may be limited, and hoarding is already occurring

DEA-registered practitioners can prescribe without an in-person interview

Guidance enables these workers to continue reporting to work

Now two-plus years on, the dispute over physician databases shows no sign of resolution

Too many states have opted out of the $18-billion agreement being negotiated in federal court

Of NDA/BLA drugs, 45% require cold-chain distribution

Trump administration drops its bombshell proposal to open up the US pharmaceutical market

January meeting will bring patient advocates, industry and regulators together

Partnership for DSCSA Governance, Inc. is up and running

Clears Senate confirmation by a 72-18 vote

Helio Health survey sees nagging compliance problems

Global Track & Trace Forum commemorates its 10th anniversary